# Phase 3 Study of EBI-005 in Dry Eye Disease

> **NCT01998802** · PHASE3 · COMPLETED · sponsor: **Eleven Biotherapeutics** · enrollment: 670 (actual)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** Active Comparator EBI-005
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01998802
- **Lead sponsor:** Eleven Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 670 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998802, "Phase 3 Study of EBI-005 in Dry Eye Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01998802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*